Literature DB >> 8708354

Staphylococcus aureus bacteremia: factors predicting hospital mortality.

J M Mylotte1, J R Aeschlimann, D L Rotella.   

Abstract

Among 89 episodes of Staphylococcus aureus bacteremia, factors identified as independent predictors of hospital mortality were Acute Physiology and Chronic Health Evaluation III score > 60 (odds ratio [OR], 3.2; 95% confidence interval [CI95], 1.7 to 5.9) and Lifestyle score > 1 (OR, 2.1; CI95, 1.2 to 3.6). Future studies of S aureus bacteremia should take into consideration acute severity of illness (as well as treatment and source of infection) when evaluating outcome.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8708354     DOI： 10.1086/647264

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  8 in total

1.  The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-14       Impact factor: 3.267

2.  Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study.

Authors:  Ram Venkatesh Anantha; Januvi Jegatheswaran; Daniel Luke Pepe; Fran Priestap; Johan Delport; S M Mansour Haeryfar; John K McCormick; Tina Mele
Journal:  CMAJ Open       Date:  2014-10-01

Review 3.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; June Myung Kim; Young Goo Song
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

5.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Sara E Cosgrove; George Sakoulas; Eli N Perencevich
Journal:  BMC Infect Dis       Date:  2011-10-19       Impact factor: 3.090

6.  Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact.

Authors:  Divya Deodhar; George Varghese; Veeraraghavan Balaji; James John; Grace Rebekah; Jeshina Janardhanan; Ranjith Jeyaraman; Sudha Jasmine; Prasad Mathews
Journal:  J Glob Infect Dis       Date:  2015 Jul-Sep

7.  Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections.

Authors:  Nobuaki Shime; Nobuyuki Saito; Miya Bokui; Naoki Sakane; Mitsuhiro Kamimura; Tsutomu Shinohara; Tadashi Kosaka; Hisashi Ishikura; Atsuko Kobayashi
Journal:  Infect Drug Resist       Date:  2018-08-06       Impact factor: 4.003

8.  Reference group choice and antibiotic resistance outcomes.

Authors:  Keith S Kaye; John J Engemann; Essy Mozaffari; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.